Cambridge Oncometrix

About:

Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer.

Website: https://cambridgeoncometrix.com/

Top Investors: MassChallenge, Pitch@Palace, Anglia Capital Group, SBRI Healthcare, i4i-connect

Description:

Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer - a condition that affects 1 in 7 men on the planet. The company develops a non-invasive risk stratification test for prostate cancer. The laboratory test will be capable of accurately selecting men for mpMRI-guided biopsy.

Total Funding Amount:

2.24M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Haverhill, Suffolk, United Kingdom

Founded Date:

2012-06-12

Contact Email:

office(AT)camonx.com

Founders:

Dmitry Soloviev, Irina Soltamova Solovyev, Istvan Boros, Maxim Rossmann, Mikhail Lomonosov, Pavel Shashkov, Sofia Zaichick

Number of Employees:

1-10

Last Funding Date:

2020-02-01

IPO Status:

Private

Industries: